User:Mr. Ibrahem/Ixazomib

Ixazomib, sold under the brand name Ninlaro, is a medication used to treat multiple myeloma. It is used together with lenalidomide and dexamethasone in people who have failed other treatment. It is taken by mouth.

Common side effects include diarrhea, constipation, low platelets, low white blood cells, peripheral neuropathy, nausea, and swelling. Other side effects may include liver problems. Use in pregnancy may harm the baby. It is a proteasome inhibitor and works by preventing protein breakdown in cells.

Ixazomib was approved for medical use in the United States in 2015 and Europe in 2016. In the United Kingdom 4 weeks of treatment costs the NHS about £6,300 as of 2021. In the United States this amount costs about 11,400 USD.